1. Home
  2. Labeler Index
  3. Alnylam Pharmaceuticals, Inc.
  4. 71336-1000
  5. NDC Package Code: 71336-1000-1 Onpattro

NDC Package 71336-1000-1 Onpattro

Patisiran Injection, Lipid Complex Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
71336-1000-1
Package Description:
1 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSE
Product Code:
71336-1000
Proprietary Name:
Onpattro
Non-Proprietary Name:
Patisiran
Substance Name:
Patisiran Sodium
Usage Information:
This medication is used to treat nerve problems due to a certain inherited condition (transthyretin-mediated amyloidosis). This condition causes a protein that your body normally makes (transthyretin-TTR), to change shape and build up in different parts of your body, which can affect the nerves, heart, and gut. This medication works by decreasing the buildup of TTR in your body.
11-Digit NDC Billing Format:
71336100001
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2053524 - patisiran lipid complex 10 MG in 5 mL Injection
  • RxCUI: 2053524 - 5 ML patisiran lipid complex 2 MG/ML Injection
  • RxCUI: 2053524 - patisiran lipid complex 10 MG per 5 ML Injection
  • RxCUI: 2053529 - onpattro 10 MG in 5 ML Injection
  • RxCUI: 2053529 - 5 ML patisiran lipid complex 2 MG/ML Injection [Onpattro]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Alnylam Pharmaceuticals, Inc.
    Dosage Form:
    Injection, Lipid Complex - [definition pending]
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • PATISIRAN SODIUM 2 mg/mL
    • Pharmacologic Class(es):
  • Decreased RNA Integrity - [PE] (Physiologic Effect)
  • Increased Protein Breakdown - [PE] (Physiologic Effect)
  • RNA, Small Interfering - [CS]
  • Small Interfering RNA - [EPC] (Established Pharmacologic Class)
  • Transthyretin-directed RNA Interaction - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    NDA210922
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    08-13-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 71336-1000-1 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    71336100001J0222Inj., patisiran, 0.1 mg0.1 MG51100100

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 71336-1000-1?

    The NDC Packaged Code 71336-1000-1 is assigned to a package of 1 vial, single-dose in 1 carton / 5 ml in 1 vial, single-dose of Onpattro, a human prescription drug labeled by Alnylam Pharmaceuticals, Inc.. The product's dosage form is injection, lipid complex and is administered via intravenous form.

    Is NDC 71336-1000 included in the NDC Directory?

    Yes, Onpattro with product code 71336-1000 is active and included in the NDC Directory. The product was first marketed by Alnylam Pharmaceuticals, Inc. on August 13, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 71336-1000-1?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 71336-1000-1?

    The 11-digit format is 71336100001. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-171336-1000-15-4-271336-1000-01